차병원

Dr. Kwang Yul Cha, Chairman of CHA Global Research Institutes, to Present Vision for K-Cell-Based Healthy Lifespan Extension and Cell Therapies at HIF 2026

  • 14th Healthcare Innovation Forum to be held December 4, with Dr. Cha delivering a keynote address
  • Keynote to highlight K-Cell-based personalized cell therapies and longevity strategies
  • Dr. Cha shares K-Cell research and future vision at international forums, including the World Knowledge Forum and ISIR World Congress
이미지1

Dr. Kwang Yul Cha, Chairman of CHA Global Research Institutes at CHA Medical Center and CHA Bio Group, will deliver a keynote address at the 2026 Healthcare Innovation Forum (HIF 2026) on December 4 at the Grand Ballroom of The Westin Josun Seoul in Jung-gu, Seoul. Hosted by ChosunBiz, the forum will be held under the theme “The Future Unlocked by Longevity: From Obesity to Innovations in Anti-Aging and Alzheimer’s Disease.”

The forum will bring together leading neuroscientists and experts from the global pharmaceutical and biotechnology industries to share the latest research findings and emerging medical technologies aimed at extending healthy lifespan. Paul Matthews, Professor at Imperial College London and Director of the Rosalind Franklin Institute, a leading authority in neuroscience, will deliver a keynote address titled “A Double Hit on the Brain: Inflammation and Energy Depletion in Alzheimer’s Disease and Multiple Sclerosis.” Dr. Hideaki Katagiri of Eli Lilly’s medical division, who was involved in the global clinical development of the Alzheimer’s disease drug Kisunla, will also present on “Lilly’s 35-Year Journey of Challenges and Innovation in Alzheimer’s Disease.”

이미지1

At the forum, which will feature experts from the global healthcare and biotechnology sectors, Dr. Cha will deliver a keynote address from 1:00 to 1:30 p.m. titled “A Bio Ecosystem for Realizing Longevity Technologies.” He will outline a future vision for extending healthy lifespan and advancing cell and gene therapies, drawing on technologies developed in infertility treatment and reproductive medicine and extending their application to research on ovarian and systemic aging.

In particular, Dr. Cha will introduce strategies centered on K-Cell, a cell-resource platform tailored to specific diseases and functions, to secure cells suited to individual patients and apply them to therapeutic development and clinical research. He will also discuss plans to establish a biotechnology ecosystem spanning detailed characterization of donors and source cells and tissues, artificial intelligence (AI)-assisted cell matching, manufacturing in accordance with Good Manufacturing Practice (GMP) standards for advanced biopharmaceuticals, first-in-human (FIH) studies, and global clinical trials.

Dr. Cha has continued to share research findings and his vision for treating intractable diseases, investigating aging, and extending healthy lifespan through K-Cell research at major conferences and forums in Korea and abroad.

이미지1

On November 6, Dr. Cha delivered a keynote address titled “Longevity & Reproductive Aging Using K-Cells” at the 16th International Society for Immunology of Reproduction (ISIR) World Congress, held at BEXCO in Busan. He outlined strategies for securing K-Cell resources and directions for developing therapies for intractable diseases, while highlighting the potential to expand research on ovarian aging toward improving women’s healthy longevity.

이미지1

Dr. Cha also presented his vision for K-Cell-centered cell therapy research at academic events in Korea and abroad in 2025. At the World Knowledge Forum’s “K-Bio Night” in September, he delivered a keynote titled “Aging Humanity and the Future of Cell Therapies,” emphasizing the importance of collaboration in securing global cell resources and developing cell-based therapeutics. At the 2025 Healthcare Innovation Forum (HIF 2025) in November, he spoke on “The Importance of K-Cell Therapies,” highlighting the need to strengthen Korea’s cell therapy research capabilities and secure cell sovereignty.

이미지1

At the Pacific Society for Reproductive Medicine (PSRM) meeting in Malaysia and the National University of Singapore (NUS)-CHA Symposium, Dr. Cha also delivered special lectures on ovarian aging and K-Cells, outlining research directions for extending technologies developed in reproductive medicine into cell therapy development.

CHA Medical Center and CHA Bio Group are expanding research on aging and healthy longevity based on technologies developed through infertility treatment, reproductive medicine, and stem cell research. Through continued development of K-Cell-based cell and gene therapies and international research collaborations, they aim to broaden therapeutic possibilities for intractable diseases and advance longevity research focused on extending healthy lifespan.

Event Overview
Event: 2026 Healthcare Innovation Forum (HIF 2026)
Date & Time: Friday, December 4, 2026 | 9:00 a.m.-4:00 p.m. (lunch provided)
Venue: Grand Ballroom, Westin Josun Hotel, Sogong-dong, Seoul, South Korea
Theme: The Future Unlocked by Longevity: From Obesity to Breakthroughs in Anti-Aging and Alzheimer's Disease
Organizer: ChosunBiz
Registration & Fees: https://e.chosunbiz.com
Inquiries: 02-724-6157, event@chosunbiz.com

이미지1
목록으로